Eris Lifesciences Ltd. Fundamental & Technical Research, Share Price Today

NSE : ERIS
NIFTY : Nifty 500
NIFTY SECTOR : Nifty MidSmall Healthcare

About Company

Eris Lifesciences Limited founded by Amit Bakshi and team in 2007 is one of the fastest growing companies within the chronic and acute categories of the Indian Branded Formulations market such as: cardiovascular; anti–diabetes; vitamins; gastroenterology and gynaecology. The company develops, manufactures and commercializes branded pharmaceutical products in select therapeutic areas within the chronic and acute categories of the IPM, such as: cardiovascular; anti-diabetics; vitamins; gastroenterology; and anti-infectives. Its focus has been on developing products in the chronic and acute category which are linked to lifestyle related disorders.

Market Cap. ₹ 20,486 Cr.

52 Week - High/Low ₹ 1,594/816

P/E Ratio 264.84

P/B Ratio 8.12

Enterprise Value ₹ -1,037 Cr.

ROE % 12.65

RSI Value 58.25

EMA 50 1413.98

EMA 200 1298.72

Market Cap. ₹ 20,486 Cr.

52 Week - High/Low ₹ 1,594/816

P/E Ratio 58.15

P/B Ratio 7.92

Enterprise Value ₹ -413 Cr.

ROE % 16.63

RSI Value 58.25

EMA 50 1413.98

EMA 200 1298.72

Add Parameters

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Terms | Privacy | Contact Us